Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Asthma |Cystic Fibrosis |Sweat Test |Acute Severe Asthma |Exacerbation of COPD |Pulmonary Embolism |Cardiogenic Pulmonary Oedema |Pneumothorax |Tension Pneumothorax |Respiratory (Chest) infections Pneumonia |Fat embolism |Hyperventilation Syndrome |ARDS |Respiratory Failure |Diabetic Ketoacidosis
Note: Bronchiectasis is a chronic destructive airway disease. Around 50% of cases are idiopathic. π¬
Cause | Description | Comments |
---|---|---|
π¦ Infections | TB, pneumonia, pertussis. | Classic global cause of airway destruction. |
𧬠Cystic Fibrosis | CFTR defect β thick mucus, chronic colonisation. | Most common genetic cause in UK/Europe. |
πͺΆ Primary Ciliary Dyskinesia | Impaired cilia β mucus retention. | Kartagenerβs (PCD + situs inversus). |
π‘οΈ Immune Deficiency | CVID, HIV, IgG subclass deficiency. | Recurrent chest infections β damage. |
πΏ ABPA | Allergic response to Aspergillus. | Often in asthmatics or CF patients. |
β»οΈ Autoimmune | RA, IBD-related lung disease. | Inflammation damages bronchi. |
π« Obstruction | Tumour, foreign body, TB nodes. | Post-obstructive dilatation. |
β Idiopathic | No identifiable cause. | ~50% of adult cases in UK. |
Test | Findings | Notes |
---|---|---|
π©Έ Bloods | βWCC, ESR/CRP in flares. | Track inflammation. |
π· CXR | Tram-tracks, ring shadows. | Suggestive, not diagnostic. |
π₯οΈ HRCT | Gold standard: airway dilation, βsignet ringβ sign. | Defines severity. |
π¨ Spirometry | Obstructive (βFEV1/FVC), mixed patterns. | Track progression. |
π§« Sputum culture | Pseudomonas, H. influenzae, Staph aureus. | Guides antibiotic therapy. |
πΏ Aspergillus precipitins | Positive in ABPA. | Helps confirm allergic component. |
π¬ Bronchoscopy | Direct view, sampling, remove foreign body. | Localised disease or malignancy suspicion. |
𧬠Genetic testing | CFTR, ciliary defects. | Young/early onset cases. |
Option | Description | Comments |
---|---|---|
ποΈ Airway Clearance | Chest physio, PEP devices, postural drainage. | Core therapy for all patients. |
π¨ Bronchodilators | SABA/LABA if coexisting asthma/COPD. | Relieves symptoms, improves clearance. |
π ICS | Not routine β consider in asthma/ABPA overlap. | Reduce airway inflammation. |
π Long-term antibiotics | Macrolides (azithromycin), inhaled aminoglycosides. | For β₯3 exacerbations/yr or Pseudomonas. |
π Vaccines | Influenza, pneumococcal. | Prevention of infection crucial. |
πͺ Surgery | Resection for severe localised disease or massive haemoptysis. | Rare, but life-saving in select cases. |
π Pulmonary rehab | Exercise + education. | Improves fitness, reduces breathlessness. |